Ping An Biomedical Co., Ltd. (PASW)

NASDAQ: PASW · Real-Time Price · USD

0.1307

-0.0082 (-5.90%)

At close: Aug 28, 2026, 4:00 PM EDT

0.1319

+0.0012 (0.92%)

After-hours: Aug 28, 2026, 5:49 PM EDT

Ping An Biomedical Balance Sheet

Financials in millions CNY. Fiscal year is October - September.

Millions CNY. Fiscal year is Oct - Sep.

Assets

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Cash & Equivalents	1.17	0.13	0.59	1.17	0.11
Short-Term Investments	-	-	-	0.07	-
Cash & Short-Term Investments	1.17	0.13	0.59	1.23	0.11
Cash Growth	795.55%	-77.88%	-52.01%	1066.71%	-33.40%
Accounts Receivable	16.93	40.44	47.09	57	49.02
Other Receivables	0.31	0.07	0.07	0.03	0.76
Receivables	17.25	40.51	47.16	57.03	49.78
Inventory	0.44	0.13	3.19	4.63	16.01
Restricted Cash	35.52	-	-	-	-
Other Current Assets	9.31	12.54	25.63	16.15	4.47
Total Current Assets	63.7	53.31	76.57	79.04	70.36
Property, Plant & Equipment	0.47	0.82	0.54	0.18	0.57
Long-Term Deferred Tax Assets	4.25	2.72	2.73	2.72	2.77
Total Assets	68.41	56.85	79.84	81.95	73.71

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Accounts Payable	9.41	15.06	9.27	18.04	7.14
Accrued Expenses	0.27	0.56	0.82	1.77	0.27
Short-Term Debt	10	10	42.5	56.1	60.74
Current Portion of Leases	0.37	0.35	0.39	0.07	0.39
Current Income Taxes Payable	-	0.33	-	1.08	0.64
Current Unearned Revenue	0.07	1.67	0.53	0.27	1.67
Other Current Liabilities	2.95	35.61	32.12	0.02	4.85
Total Current Liabilities	23.08	63.58	85.63	77.35	75.7
Long-Term Leases	0.1	0.46	0.07	-	0.07
Total Liabilities	23.17	64.04	85.7	77.35	75.77

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Common Stock	0.01	0.01	0.01	0.01	0.01
Additional Paid-In Capital	66.21	-	-	-	0
Retained Earnings	-19.37	-6.54	-4.94	5.66	-1.57
Comprehensive Income & Other	-1.61	-0.66	-0.93	-1.07	-0.5
Shareholders' Equity	45.24	-7.19	-5.86	4.6	-2.06
Total Liabilities & Equity	68.41	56.85	79.84	81.95	73.71

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Sep '25 Sep 30, 2025	Sep '24 Sep 30, 2024	Sep '23 Sep 30, 2023	Sep '22 Sep 30, 2022	Sep '21 Sep 30, 2021
Total Debt	10.47	10.81	42.96	56.16	61.2
Net Cash (Debt)	-9.3	-10.68	-42.36	-54.93	-61.09
Net Cash Growth	-	-	-	-	-
Net Cash Per Share	-0.50	-0.59	-2.35	-3.05	-3.39
Filing Date Shares Outstanding	24.55	18	18	18	18
Total Common Shares Outstanding	20.5	18	18	18	18
Working Capital	40.62	-10.27	-9.06	1.69	-5.34
Book Value Per Share	2.21	-0.40	-0.33	0.26	-0.11
Tangible Book Value	45.24	-7.19	-5.86	4.6	-2.06
Tangible Book Value Per Share	2.21	-0.40	-0.33	0.26	-0.11
Machinery	0.1	0.1	0.1	0.1	0.07